Abstract:The present study was performed in order to elucidate the mechanism of the recruitment of follicular growth and subsequent ovulation after ovarian wedge resection (WR). Seven patients with a diagnosis of PCO underwent WR. After taking 4 or 5 preoperative blood samples in the morning after their hospitalization, blood was obtained following the operation at 3-h intervals for the first 48h and at 1-3day intervals thereafter for 9-33days. These samples were analyzed for LH, FSH, estradiol, progesterone and androstenedione. Each ovarian tissue obtained by the operation was processed for histological examination. In 5 patients, the ovaries appeared to correspond with typical PCO. In the remaining 2 patients, the histological features of the ovaries were consistent with a type of screlocystico-atrophic ovary according to Kusuda (1979). Some characteristic postoperative hormonal changes were observed in the patients with typical PCO who ovulated postoperatively. FSH started to increase from 3 to 30h after WR, and remained at higher levels for 2-7days. LH increased in a sporadic form shortly after WR and then declined in spite of sustained higher levels of FSH. Preoperative levels of androstenedione in the patients with typical PCO ranged between 2.0-3.4ng/ml, which exceeded serum levels in normal women. These high levels of androstenedione fell gradually following WR. There was an apparent decline of estradiol after WR in 2 out of 5 patients who ovulated postoperatively. A minor increase in progesterone occurred shortly after the operation, followed by a prompt decrease. In contrast, postoperative hormonal changes were minimal in the patients who did not ovulate postoperatively. The postoperative hormonal changes including a decline in androstenedione, a temporary-minor increase in progesterone, a short-term sporadic increase in LH and a sustained increase in FSH may be involved in the mechanisms which account for the recruitment of follicular growth and subsequent ovulation after WR.

The research progress of GATA6 in heart development and isolated atrial septal defect

NEXN Inhibits GATA4 and Leads to Atrial Septal Defects in Mice and Humans

Hormonal contributions to the recruitment of follicular development following ovarian wedge resection in polycystic ovary syndrome.

Regulation of GATA4 Transcriptional Activity in Cardiovascular Development and Disease.

GATA6 regulates WNT and BMP programs to pattern precardiac mesoderm during the earliest stages of human cardiogenesis

Gata6 functions in zebrafish endoderm to regulate late differentiating arterial pole cardiogenesis

The emerging role of GATA transcription factors in development and disease

Flucloxacillin Induced Liver Disease: Histopathological Findings At Biopsy And Autopsy

Identification of Functional Mutations in GATA4 in Patients with Congenital Heart Disease

GATA transcription factors in vertebrates: evolutionary, structural and functional interplay

Molecular Mechanism Study on GATA-4 M310V Gene Mutation Involved in Patients With Familial Atrial Septal Defect

The Function of GATA Family in Cell Fate Determination

[Research Progress on Genetic and Epigenetic Mechanisms in Congenital Heart Disease].

Sequence variations in GATA4 and CITED2 gene among patients with cardiac septation defects from Xinjiang, China

Functional analysis of the congenital heart disease‑associated GATA4 H436Y mutation in vitro.

[Role of GATA-4 in Cardiac Development and Remodeling].

Functional Analysis of Rare Variants of GATA4 Identified in Chinese Patients with Congenital Heart Defect

GATA transcription factors in development and disease

GATA4 Transgenic Mice As an in Vivo Model of Congenital Heart Disease.

Dynamic GATA4 Enhancers Shape the Chromatin Landscape Central to Heart Development and Disease.

A novel mutation in GATA4 gene associated with dominant inherited familial atrial septal defect.